CLINICAL_TRIALS
trial_result
· 2010-02-02
Clinical Trial Update: Nifedipine (Adalat CR, BAY A1040) High Dose PK/PD Study [Phase 2]
Summary
Phase 2 high-dose PK/PD study of nifedipine (Adalat CR) for hypertension has completed and results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Bayer | Conditions: Hypertension | Phase 2 | Status: COMPLETED | Results posted: 2010-02-02